('and', 56)('of', 23)('the', 19)('for', 18)('in', 16)('data', 15)('to', 13)('a', 12)('Leidos', 12)('analysis', 12)('-', 10)('The', 10)('with', 10)('as', 10)('Frederick', 9)('MD', 8)('is', 8)('support', 8)('NCI', 7)('development', 7)('160', 7)('sequencing', 7)('be', 6)('experience', 6)('Biomedical', 6)('Research', 6)('Bioinformatics', 5)('bioinformatics', 5)('NGS', 5)('s', 5)('8217', 5)('an', 5)('at', 5)('such', 4)('quality', 4)('Inc.', 4)('will', 4)('technology', 4)('Analyst', 4)('provides', 4)('research', 3)('activities', 3)('skills', 3)('degree', 3)('commercial', 3)('employees', 3)('Group', 3)('from', 3)('must', 3)('high', 3)('including', 3)('investigators', 3)('related', 3)('National', 3)('management', 3)('approximately', 3)('Cancer', 3)('Experience', 3)('cancer', 3)('Center', 3)('processing', 3)('QUALIFICATIONS', 2)('four', 2)('facilities', 2)('issues', 2)('environment', 2)('Facility', 2)('positions', 2)('team', 2)('biological', 2)('Systems', 2)('current', 2)('&#', 2)('Technology', 2)('visit', 2)('assessment', 2)('more', 2)('this', 2)('FFRDC', 2)('information', 2)('1', 2)('vital', 2)('Sequencing', 2)('may', 2)('mapping', 2)('effective', 2)('operations', 2)('years', 2)('biomedical', 2)('Information', 2)('customers.', 2)('performance', 2)('(NCI)', 2)('considered', 2)('QC', 2)('UnitedHealth', 2)('(', 2)('candidates', 2)('For', 2)('FNLCR', 2)('discovery', 2)('missions', 2)('annual', 2)('expression', 2)('ABCC', 2)('Philadelphia', 2)('these', 2)('company&#', 2)('Candidates', 2)(')', 2)('Institute', 2)('programs', 2)('well', 2)('position', 2)('$', 2)('application', 2)('4', 2)('has', 2)('government', 2)('using', 2)('biology', 2)('scientific', 2)('business', 2)('efforts', 2)('or', 2)('within', 2)('clinical', 2)('delivery', 2)('computing', 2)('laboratory', 2)('DESCRIPTION', 2)('breadth', 1)('all', 1)('represent', 1)('global', 1)('results', 1)('manages', 1)('under', 1)('health', 1)('include', 1)('veterans', 1)('trillions', 1)('markets.', 1)('entire', 1)('open-source', 1)('Global', 1)('next-gen', 1)('M.', 1)('design', 1)('PREFERRED', 1)('FNLCR&#', 1)('college/university', 1)('established', 1)('GS).', 1)('giving', 1)('COMPANY', 1)('investigator-initiated', 1)('experiment', 1)('run', 1)('designing', 1)('new', 1)('supporting', 1)('(IS&amp', 1)('(FFRDC)', 1)('delivering', 1)('desired', 1)('focused', 1)('others', 1)('strong', 1)('(LBRI)', 1)('900', 1)('33', 1)('TCGA', 1)('women', 1)('throughput', 1)('(SF)', 1)('gene', 1)('manage', 1)('PERL', 1)('tools', 1)('genomics', 1)('working', 1)('next', 1)('Analyst&#', 1)('bases', 1)('troubleshooting', 1)('Lockheed', 1)('&amp', 1)('equivalency', 1)("Children's", 1)('languages', 1)('science', 1)('work', 1)('following', 1)('MiSeq.', 1)('revenues', 1)('SF', 1)('scripting', 1)('dedicated', 1)('process', 1)('Familiarity', 1)('sample', 1)('effectively', 1)('minimum', 1)('third-generation', 1)('Exome-seq', 1)('SNP/structural', 1)('biopharmaceutical', 1)('animal', 1)('Opportunity', 1)('A', 1)('description', 1)('after', 1)('variant', 1)('Foreign', 1)('applications', 1)('core', 1)('preferential', 1)('documentation', 1)('platforms.', 1)('maintain', 1)('preventive', 1)('webpage', 1)('ended', 1)('below:', 1)('its', 1)('Higher', 1)('forma', 1)('accredited', 1)('Bachelor&#', 1)('JOB', 1)('Qualified', 1)('degrees', 1)('2016', 1)('emailed', 1)('combination', 1)('seeking', 1)('python', 1)('Michael', 1)('NIH', 1)("Ke'aki", 1)('(CHEA)', 1)('metagenomics', 1)('workflows', 1)('not', 1)('possess', 1)('proteins', 1)('NIAID.', 1)('(ABCC)', 1)('Council', 1)('apply.', 1)('|', 1)('financial', 1)('Accreditation', 1)('generation', 1)('challenges', 1)('our', 1)('operation', 1)('publically', 1)('research.', 1)('(Masters', 1)('Practice', 1)('wholly', 1)('safety', 1)('receiving', 1)('AIDS.', 1)('assurance', 1)('available.', 1)('high-performance', 1)('This', 1)('technologies.&#', 1)('Work', 1)('diagnostic', 1)('imaging', 1)('members', 1)('training', 1)('Education', 1)('programming', 1)('homeland', 1)('000', 1)('1000', 1)('450', 1)('proteomics', 1)('owned', 1)('Program', 1)('RNA-seq', 1)('robust', 1)('AIDS', 1)('given', 1)('interact', 1)('their', 1)('consultation', 1)('listed', 1)('molecular', 1)('Data', 1)('Hospital', 1)('pipelines', 1)('that', 1)('completed', 1)('part', 1)('to:', 1)('10', 1)('jobs', 1)('Employer.', 1)('future', 1)('next-generation', 1)('providing', 1)('pro', 1)('spectrum', 1)('PhD', 1)('BASIC', 1)('Administrative', 1)('Development', 1)('Diseases', 1)('responsible', 1)('Virginia', 1)('sciences', 1)('which', 1)('January', 1)('toughest', 1)('multiple', 1)('collaboration', 1)('who', 1)('Equal', 1)('state-of-the-art', 1)('sponsored', 1)('services', 1)('hands-on', 1)('Overview:', 1)('STULZ', 1)('R', 1)('www.Leidos.com.', 1)('assembling', 1)('solutions', 1)('knowledge', 1)('R&amp', 1)('only', 1)('Federally', 1)('preferred)', 1)('express', 1)('Funded', 1)('Chip-seq', 1)('processes', 1)('resource', 1)('calling', 1)('through', 1)('interpretation.', 1)('intelligence', 1)('national', 1)('operates', 1)('defense', 1)('are', 1)('genomic', 1)('encouraged', 1)('ENCODE', 1)('Good', 1)('please', 1)('Recruiters', 1)('protected', 1)('tens', 1)('Technologies', 1)('conditions', 1)('Advanced', 1)('available', 1)('recently', 1)('opening', 1)('U.S.', 1)('control/quality', 1)('collaborators', 1)('reported', 1)('many', 1)('according', 1)('drug', 1)('minorities', 1)('Through', 1)('Laboratory', 1)('PacBio', 1)('3000', 1)('spans', 1)('throughout', 1)('addition', 1)('been', 1)('.', 1)('interest', 1)('500', 1)('systems', 1)('thousand', 1)('protocols', 1)('sound', 1)('developing', 1)('budget', 1)('evaluated', 1)('Responsible', 1)('You', 1)('Research.&#', 1)('member', 1)('Of', 1)('products', 1)('several', 1)('Hands-on', 1)('status', 1)('independent', 1)('used', 1)('effect', 1)('{emailaddress}', 1)('levels', 1)('Raleigh', 1)('frequently', 1)('Reston', 1)('minimally', 1)('PA', 1)('It', 1)('procurement', 1)('practices', 1)('solve', 1)('In', 1)('scientists', 1)('meet', 1)('abilities', 1)('CCR', 1)('sources', 1)('Responsibilities', 1)('identify', 1)('alternative', 1)('HiSeq', 1)('candidate', 1)('LBRI', 1)('processes.&#', 1)('instrument', 1)('samples', 1)('relevance', 1)('D', 1)('evaluate', 1)('Air', 1)('background', 1)('Unix/Linux', 1)('nanotechnology', 1)('unique', 1)('advanced', 1)('like', 1)('success', 1)('NCBI', 1)('Computing', 1)('annually', 1)('individuals', 1)('hypothesis-driven', 1)('become', 1)('security', 1)('therapeutic', 1)('Management', 1)('Java', 1)('Illumina', 1)('Genomes', 1)('platforms', 1)('accelerate', 1)('issues.&#', 1)('Possession', 1)('provided', 1)('genetics', 1)('Headquartered', 1)('integration', 1)('does', 1)('Description:', 1)('leader', 1)('(FNLCR).', 1)('INFORMATION', 1)('assembly', 1)('Infectious', 1)('Ensembl', 1)('manufacturing', 1)('by', 1)('on', 1)('about', 1)('staff.', 1)('disabilities', 1)('Proven', 1)('Solutions', 1)('software', 1)('pipelines.', 1)('Knowledge', 1)('(NIAID)-sponsored', 1)('civil', 1)('instruments', 1)('into', 1)('PROGRAM', 1)('analysis.', 1)('lieu', 1)('sequence', 1)('start', 1)('world&#', 1)('fiscal', 1)('consideration:', 1)('Science', 1)('but', 1)('construction', 1)('subsidiary', 1)('operating', 1)('(NCI).', 1)('NextSeq', 1)('etc.', 1)('Nanotherapeutics', 1)('required', 1)('USA', 1)('year', 1)('To', 1)('diverse', 1)('trials', 1)('Research.', 1)('Proficiency', 1)('field', 1)('other', 1)('genome', 1)('you', 1)('Manufacturing', 1)('generates', 1)("Martin's", 1)('variation', 1)('science/bioinformatics/math/computer', 1)('Qualifications:', 1)('Page', 1)('billion', 1)('Allergy', 1)('investigators.', 1)('Jobs.com', 1)    Bioinformatics Analyst (NCI) - Leidos | Jobs.com
         Description:
          COMPANY INFORMATION
         Leidos Biomedical Research, Inc. (LBRI), a wholly owned subsidiary of Leidos, operates the Frederick National Laboratory for Cancer Research (FNLCR). FNLCR is a Federally Funded Research and Development Center (FFRDC) sponsored by the National Cancer Institute (NCI). It is the only FFRDC dedicated to biomedical research. Through its status as an FFRDC, FNLCR provides NCI and others with a unique national resource to accelerate the development and delivery of effective preventive, diagnostic, and therapeutic products for cancer and AIDS.
         The breadth of FNLCR&#8217;s activities spans the research and development spectrum, including investigator-initiated, hypothesis-driven research into cancer and AIDS; advanced technology programs focused on genetics and genomics, proteins and proteomics, imaging, nanotechnology, bioinformatics, and laboratory animal sciences; clinical operations in support of NCI and National Institute of Allergy and Infectious Diseases (NIAID)-sponsored clinical trials, as well as NCI drug discovery and development efforts; and management and operations of biopharmaceutical development and manufacturing programs under current Good Manufacturing Practice conditions for NCI and NIAID. Administrative, procurement, financial, safety, and facilities support is provided to these R&amp;D activities through state-of-the-art business processes.&#160; LBRI has approximately 1,900 employees and manages an annual operating budget of approximately $450M.
         For more information about Leidos Biomedical Research Inc., please visit our webpage at
         .
          PROGRAM DESCRIPTION
         The Advanced Biomedical Computing Center (ABCC) is a part of the Data Science and Information Technology Program at Leidos Biomedical Research, Inc. The ABCC provides technology development, scientific consultation, collaboration and training, and high-performance computing support to the NCI and NIH scientists and staff. The Sequencing Facility (SF) has been established to manage the operation of multiple platforms for next-gen and third-generation sequencing in support of NCI investigators. The SF provides services to many CCR investigators and their collaborators, processes several thousand samples and generates tens of trillions bases of sequencing data annually using such instruments as the HiSeq 3000, NextSeq 500, PacBio and MiSeq.
          JOB DESCRIPTION
         This position description does not represent a current opening but may be used to identify candidates with skills and experience for positions within Leidos Biomedical Research that frequently become available. Candidates who express an interest may be considered for future positions at Leidos Biomedical Research.
         The ABCC is seeking Bioinformatics Analyst candidates at all levels to work in the Sequencing Facility Bioinformatics Group, which provides bioinformatics support for investigators within the NCI Center for Cancer Research.&#160;The Bioinformatics Analyst&#160;will be responsible for providing bioinformatics support including the management and analysis of high throughput next-generation sequencing data from Illumina and other NGS platforms. Responsible for troubleshooting instrument run issues, data processing issues, and sample performance issues.&#160;&#160;Analyst will evaluate alternative analysis applications as well as software pipelines.
         Responsibilities include data processing and management, NGS data QC, mapping, genome assembly, gene expression analysis, SNP/structural variation discovery; designing and developing robust QC and analysis workflows for supporting new sequencing protocols and technologies.&#160;&#160;Work effectively as a member of a team, following sound scientific practices and maintain effective documentation of activities and analysis. In addition, interact with members at core facilities, investigators throughout the entire process from experiment design, data quality assessment, data analysis, to data delivery and results interpretation.
         Qualifications:
          BASIC QUALIFICATIONS
          To be considered for this position, you must minimally meet the knowledge, skills, and abilities listed below:
          Possession of a Bachelor&#8217;s degree (Masters or PhD degree preferred) from an accredited college/university according to the Council for Higher Education Accreditation (CHEA) in biomedical science/bioinformatics/math/computer related field or four (4) years related experience in lieu of degree
          Foreign degrees must be evaluated for U.S. equivalency
          A minimum of four (4) years related experience in a biological research laboratory environment with a strong background in bioinformatics application development
          The candidate must possess experience in genomic and sequence analysis such as RNA-seq, Exome-seq, Chip-seq and metagenomics analysis, construction of data processing pipelines, and quality control/quality assurance analysis
          Hands-on experience in next generation sequencing analysis, including data quality assessment, sequencing data assembling, mapping, variant calling, and expression analysis
          Proficiency in Unix/Linux scripting, and programming languages such as PERL, python, R, Java, and hands-on experience with commercial and open-source bioinformatics and NGS data analysis tools is required
          PREFERRED QUALIFICATIONS
          Candidates with these desired skills will be given preferential consideration:
          Experience in NGS sequencing technology and molecular biology
          Knowledge of cancer biology
          Experience using high performance computing systems for NGS analysis
          Experience in data integration and application development
          Familiarity with publically available data sources such as ENCODE, Ensembl, NCBI, TCGA, 1000 Genomes, etc.
          Proven success in independent efforts and delivering high quality data with biological relevance in a team environment
          Leidos Overview:
         Leidos is a global science and technology solutions leader working to solve the world&#8217;s toughest challenges in the defense, intelligence, homeland security, civil, and health markets. The company&#8217;s 33,000 employees support vital missions for government and commercial customers. Headquartered in Reston, Virginia, Leidos reported pro forma annual revenues of approximately $10 billion for the fiscal year ended January 1, 2016 after giving effect to the recently completed combination of Leidos with Lockheed Martin's Information Systems &amp; Global Solutions business (IS&amp;GS). For more information, visit www.Leidos.com.  The company&#8217;s diverse employees support vital missions for government and commercial customers. Qualified women, minorities, individuals with disabilities and protected veterans are encouraged to apply.     Leidos is an Equal Opportunity Employer.
             STULZ Air Technology Systems, Inc., Frederick - MD
             Ke'aki Technologies, Frederick - MD
             Children's Hospital Of Philadelphia, Philadelphia - PA
             Management Recruiters of Raleigh, Frederick - MD
             Frederick - MD
             Michael Page USA, Frederick - MD
             Nanotherapeutics, Frederick - MD
             UnitedHealth Group, Frederick - MD
             UnitedHealth Group, Frederick - MD
          Bioinformatics Analyst (NCI)
        You will start receiving jobs like this emailed to: {emailaddress}